DANONE :

Paris, October 1, 2026, at 5:45 PM CEST

Q3 2026 Sales Aide-Mémoire

Danone has compiled this document that sets forth public information previously provided by the Company, ahead of Q3 2026 sales, due for publication on October 28, 2026.

Please refer to Danone’s Results Center for copies of Press Releases, Presentations, Webcasts and Transcripts. This can be found on Danone’s Investor Relations website: https://www.danone.com/investor-relations/results-center.html

I. 2026 GUIDANCE

The guidance for FY 2026, issued in February 2026 and confirmed in July 2026, is in line with the mid-term ambition issued in June 2024:

Like-for-like sales growth between 3% and 5%
- Recurring operating income growing faster than sales

II. SALES

In H1 2026, sales were up 3.5% on a like-for-like (LFL) basis, with an increase of 1.7% in volume/mix and 1.8% in price.
In more details:

In Q1, the Company reported LFL sales growth of 2.7%, with 1.5% volume/mix and 1.2% price.
In Q2, the Company reported LFL sales growth of 4.2%, with 1.9% volume/mix and 2.3% price.

On a reported basis, H1 2026 sales increased by 1.4%, including, in addition to the LFL sales growth:

A negative impact from forex (-3.3%);
A positive impact from scope ( 0.7%), resulting predominantly from the acquisition of Kate Farms on July 1, 2025; and
A positive contribution from hyperinflation ( 0.3%).

Changes in scope

Danone has acquired on February 12, 2026, an additional 1% stake in its Australian Dairy joint-venture with Saputo Dairy Australia after exercising its call option, bringing its ownership to 51% and resulting in the financial consolidation of this business.
Danone and Arcor completed on August 1, 2026, the creation of their joint venture in Argentina, which is thus reflected since August 1st, 2026, within ‘equity-accounted companies’ in Danone’s financial statements, based on the 50% shareholding. As a result, Danone’s EDP business in Argentina is included in the scope effect from Q3 2026 onwards.
Danone completed on September 4, 2026, the acquisition of Huel, a leading player in complete, nutritionally balanced meal solutions. Huel is consolidated in Danone’s financial statements from September 1, 2026 and therefore included in the scope effect from Q3 2026 onwards.
The Akkermansia Company (TAC) and Kate Farms were acquired respectively on June 25, 2025 and July 1, 2025, and are no longer included in the scope effect but in the like-for-like performance from Q3 2026.

For further details on the main changes in scope in 2025 and in H1 2026, please refer to Note 4.2 of the 2025 consolidated financial statements and Note 6.1 of the 2026 interim financial report

Commentary about LFL growth components
In Q2 2026, sales stood at €7,215m, up 4.2% LFL, with a contribution of 1.9% from volume/mix and 2.3% from
price. ⁽¹⁾

“We will increase prices selectively across the regions as we go through the third quarter already.” ⁽³⁾

“We are doing price increases as we speak in many, many markets.”⁽⁴⁾

Commentary by geographical zone

Europe, Middle East and Africa (EMEA)
Momentum in the EMEA region improved in Q2. Sales were up 3.6% LFL, led by volume/mix at 2.2% and price at 1.5%. Within the region, Europe delivered LFL sales growth of 0.6%, with volume/mix at 0.3% and price at 0.3% ⁽¹⁾⁽²⁾

“For IMF in EMEA, we are now back to a normal situation in terms of presence on shelf. Our focus has now shifted from restoring supply to rebuilding trust in the category.” ⁽³⁾
- “In the Middle East, we lost a lot of sales in Q1. It bounced back very quickly in Q2, and we are back to where we used to be, in a way, in terms of distribution, sell-out and market shares.”⁽⁴⁾
- “Europe is a mixed bag. What we are seeing is that the category is going a little bit slower. So there is still credibility to be rebuilt, especially by the leading brands in that sector, and we are confident that we can do that.” ⁽⁴⁾
- “In Q3, we will launch a new campaign to support these efforts and remind consumers of the quality, nutrition, and expertise that comes with our 50 years of early life nutrition research. Although the disruption affecting IMF market continued into quarter two, we expect the market to progressively normalize throughout the remainder of the year.” ⁽³⁾
“In Q2, our Waters business delivered a solid start to the season, notably driven by our Volvic and evian brands with both plain water and recent aqua drinks innovations under the Volvic brand growing very fast.”⁽³⁾

Americas
In the Americas, sales were up 4.3% LFL in Q2, with volume/mix at 0.3% and price up 4.0%. Within the region, North America posted LFL sales growth of 2.6%, with volume/mix at 0.7% and price at 2.0%.⁽¹⁾

“In North America, we have previously discussed our dissatisfaction with the competitiveness of parts of our EDP portfolio. We saw some improvements in performance during Q2, which is encouraging. That said, we are still only at the beginning of the journey, and we remain focused on sequentially executing the initiatives that are needed to deliver a sustained improvement in performance overtime.” ⁽³⁾
“Specialized Nutrition performed well across the region in Q2, the Infant Milk formula business in Latin America was particularly strong, growing double-digits, driven by the Aptamil brand.”⁽³⁾

Asia Pacific (APAC)
APAC delivered 5.2% like-for-like sales growth in Q2, with volume/mix at 3.5% and price at 1.6%. Within the region, China, North Asia & Oceania (CNAO) posted LFL sales growth of 3.6% with volume/mix at 1.5% and price at 2.2%. ⁽¹⁾

“In IMF China, we delivered in Q2 competitive growth in a category that has been normalizing and against high level of comps of last year.” ⁽³⁾
“As a reminder, the standout in Q3 2025 was the China, North Asia and Oceania zone; the TEAM around Bruno delivered exceptional growth in this part of the world, with all sub-regions contributing strongly from China to Japan to Oceania.” ⁽⁵⁾
"When we talk about normalization of everything we see there, it means that yes, the expectation is to go back to mid-single digit contribution over the years to come, thanks to medical nutrition growth and thanks to market share wins in early life nutrition, I think we have everything it takes to continue winning that market.”⁽⁴⁾
“We talked Mizone, which was a drag in Q2, which probably will remain a drag in Q3 because the season is not good for beverage companies in China. We know that Indonesia has been very strong in Q2, helped by weather conditions, exactly the opposite of what we are having in China.” ⁽⁴⁾

Sources
            ⁽¹⁾2026 H1 Results Press Release
            ⁽²⁾2026 H1 Results Investor Presentation
            ⁽³⁾2026 H1 Results Investor Call Transcript
            Transcript⁽⁴⁾ of the fireside chat at Barclays Global Consumer Conference on September 8, 2026, between Barclays analyst Warren Ackerman, Danone CEO Antoine de Saint-Affrique and DANONE CFO Juergen Esser.
            ⁽⁵⁾2025 Q3 Sales Investor Call Transcript

VI. APPENDIX

Quarterly topline evolution

Quarterly sales and volume/mix by geography and by category

The regional presentation of sales below reflects the three new geographical zones announced by the company, effective January 1, 2026: EMEA (Europe, Middle East and Africa), the Americas and APAC (Asia Pacific).

Please see the Company’s Press release of March 17, 2026, for more detail.

	Q3 2025		Q4 2025				FY 2025			Q1 2026		Q2 2026
	LFL growth	Vol/mix	LFL growth		Vol/mix		LFL growth		Vol/mix	LFL growth	Vol/mix	LFL growth	Vol/mix
By geographical zone
EMEA	4.6%	2.5%		4.3%		2.0%		3.9%	2.3%	0.6%	-1.4%	3.6%	2.2%
Americas	2.3%	-0.5%		3.0%		-0.4%		3.2%	-0.1%	3.4%	2.5%	4.3%	0.3%
APAC	9.0%	10.2%		8.3%		8.4%		7.6%	7.9%	6.0%	6.2%	5.2%	3.5%
By category
EDP	3.5%	1.7%		3.8%		1.6%		3.5%	1.7%	3.4%	2.1%	3.8%	2.4%
Specialized Nutrition	8.3%	6.5%		7.2%		5.4%		7.4%	5.5%	1.9%	1.3%	4.5%	0.7%
Waters	2.3%	1.3%		2.2%		-0.5%		1.9%	0.3%	2.3%	0.3%	4.7%	2.6%

TOTAL	4.8%	3.2%		4.7%		2.5%		4.5%	2.7%	2.7%	1.5%	4.2%	1.9%

Quarterly sales by geography by category

Q3 2025	EMEA		Americas		APAC		Total
Q3 2025	Sales (€m)	LFL sales growth (%)	Sales (€m)	LFL sales growth (%)	Sales (€m)	LFL sales growth (%)	Sales (€m)	LFL sales growth (%)

EDP	1,404	3.8%	1,748	2.7%	103	14.3%	3,255	3.5%
Specialized Nutrition	1,058	5.8%	273	8.1%	969	11.1%	2,299	8.3%
Waters	645	4.4%	233	-5.5%	444	3.5%	1,322	2.3%
Total Company	3,107	4.6%	2,253	2.3%	1,516	9.0%	6,876	4.8%

Q4 2025	EMEA		Americas		APAC		Total
Q4 2025	Sales (€m)	LFL sales growth (%)	Sales (€m)	LFL sales growth (%)	Sales (€m)	LFL sales growth (%)	Sales (€m)	LFL sales growth (%)

EDP	1,428	4.4%	1,757	2.5%	103	19.4%	3,288	3.8%
Specialized Nutrition	1,063	3.4%	287	9.6%	1,022	10.6%	2,372	7.2%
Waters	510	5.8%	239	0.9%	274	-2.4%	1,023	2.2%
Total Company	3,002	4.3%	2,283	3.0%	1,399	8.3%	6,684	4.7%

FY 2025	EMEA		Americas		APAC		Total
FY 2025	Sales (€m)	LFL sales growth (%)	Sales (€m)	LFL sales growth (%)	Sales (€m)	LFL sales growth (%)	Sales (€m)	LFL sales growth (%)

EDP	5,641	3.3%	7,108	3.2%	409	12.7%	13,158	3.5%
Specialized Nutrition	4,273	4.4%	991	10.6%	4,013	9.9%	9,277	7.4%
Waters	2,298	4.4%	1,009	-2.2%	1,541	1.1%	4,848	1.9%
Total Company	12,212	3.9%	9,108	3.2%	5,963	7.6%	27,283	4.5%